Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP6988.RAQvI8VLoQt2qWxtD_bUv5oBi_MCWh3HytLrKjE17oYBk#assertion> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion wasGeneratedBy ECO_0000203 provenance.
- assertion wasDerivedFrom BEFREE provenance.
- assertion SIO_000772 14976243 provenance.
- assertion evidence source_evidence_literature provenance.
- assertion description "[The ABL inhibitor Imatinib (Gleevec, STI571) has remarkable efficacy for treating chronic phase CML, and FLT3 inhibitors (e.g., PKC412) show similar promise in preclinical studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.